-
Five reasons to invest- Leading positions in attractive pharma markets
- Unique offering: Specialty products made of glass and plastic
- Leading international manufacturer of high-quality specialty
glass and plastic products for the global pharma and healthcare industry - Long-term relationships with top-notch pharma customers
- Sustainable strategy for profitable growth
-
Megatrends that influence
our strategy- Rise in chronic diseases and aging population
- Rapid growth in generics
- Growing healthcare provision in emerging markets
- Stricter regulatory requirements
- New drugs, especially in biosimilars and biotech
- Growing trend toward self-medication
-
As of 2020, Gerresheimer AGreceived an MSCI Rating of AA
